Previous Page  4 / 16 Next Page
Information
Show Menu
Previous Page 4 / 16 Next Page
Page Background

Page 34

allied

academies

Biol Med Case Rep 2017 | Volume 1 Issue 2

November 06-07, 2017 | New Orleans, USA

Nanomedicine & Healthcare

Global Meet on

N

anobioinformatics is a convergent field which integrates

the science of nanotechnology with bioinformatics.

Nanobioinformatics has the potential to solve problems

regarding high throughput genomics data, novel biomarker

discovery, complex biological systems, computer-aided drug

design (CADD), and nanobiology. Also, nanobioinformatics

can be used for devising and designing of different

nanosystems. In this context, for instance, bioinformatics

can efficiently facilitate identification of multiplexed probes

in a nanoparticle. Nano drugs are capable of cell targeting,

penetration, and controlled release. Today, the application

of nanobiotechnology in drug delivery systems is well-

known. Bioinformatics is an important predictive approach

for designing nano-transport systems for specific drugs.

Also, integration of the power of two chem/bioinformatic

techniques, molecular dynamics (MD) and docking, with

statistics can help prediction of the efficiency of drug loading

in nanoparticles. In addition, in the context of in-silico

drug design, nano-design through nanoscale simulation

and modeling requires cheminformatic and bioinformatic

techniques such as MD simulations, quantitative structure–

activity relationship (QSAR), molecular mechanics and

quantum mechanics. A growing number of publically

available databases such as nanoparticle ontology and

chemical entities of biological interest can be used to retrieve

required data for nanobioinformatic drug design. Altogether,

nanobioinformatics is a novel multidisciplinary field with

many potential capabilities in drug design and delivery

systems which may significantly accelerate the treatment

many deadly diseases including cancer.

Speaker Biography

Abbas is a student currently living in Tehran, Iran. He completed his diploma in biology

at the age of 18 years (2011) from Shahid Beheshti High School. Then, he obtained a

B.Sc

. degree in Genetics from the Shahid Chamran University of Ahvaz in spring 2015.

Now, he is studying Masters of Biochemistry at the University of Kashan. His special

research interests range from Bioinformatics to Drug Design focusing on melanoma

and lung cancer. He is also interested in Epigenetics.

e:

abbas.salavaty@gmail.com

Application of nanobioinformatics in drug design and delivery systems

Abbas Salavaty

and

Mozhdeh Shahmoradi

University of Kashan, Iran